Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015, Article ID 906026, 6 pages
http://dx.doi.org/10.1155/2015/906026
Research Article

Role of the Aspartate Transaminase and Platelet Ratio Index in Assessing Hepatic Fibrosis and Liver Inflammation in Adolescent Patients with HBeAg-Positive Chronic Hepatitis B

1Department of Infectious Diseases and Shenzhen Key Lab for Endogenous Infection, Shenzhen Nanshan Hospital, Guangdong Medical College, No. 89, Taoyuan Road, Nanshan District, Shenzhen 518052, China
2Department of Gastroenterology, The Central Hospital of Wuhan, No. 26, Jianghan Road, Wuhan, China
3Institute of Infectious Diseases and Medical Center for Liver Failure, Beijing 302 Hospital, Beijing, China
4Department of Liver Diseases, Huizhou Municipal Central Hospital, No. 41 Eling North Road, Huizhou, China

Received 17 March 2015; Revised 11 June 2015; Accepted 14 June 2015

Academic Editor: John N. Plevris

Copyright © 2015 Yu Zhijian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Lozano, M. Naghavi, K. Foreman et al., “Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010,” The Lancet, vol. 380, no. 9859, pp. 2095–2128, 2012. View at Publisher · View at Google Scholar
  2. Y.-T. Sun, Y.-X. Zhang, H. Tang et al., “Clinical characteristics and current management of hepatitis B and C in China,” World Journal of Gastroenterology, vol. 20, no. 37, pp. 13582–13590, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Walsh, A. Verster, M. Rodolph, and E. A. Akl, “WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs,” International Journal of Drug Policy, vol. 25, no. 3, pp. 363–371, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. M.-C. Rousselet, S. Michalak, F. Dupré et al., “Sources of variability in histological scoring of chronic viral hepatitis,” Hepatology, vol. 41, no. 2, pp. 257–264, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Assal, D. Mackie, and C. L. Cooper, “Transient elastography, APRI, and ultrasound have minimal utility in chronic low-replicative hepatitis B infection,” European Journal of Gastroenterology and Hepatology, vol. 26, no. 9, pp. 1010–1014, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Ozyalvacli, A. Kucukbayrak, M. Kurt et al., “Non-invasive fibrosis tests are correlated with necroinflammatory actvity of liver in patients with chronic hepatitis B,” Clinica Terapeutica, vol. 165, no. 3, pp. e199–e204, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Celikbilek, S. Dogan, S. Gursoy et al., “Noninvasive assessment of liver damage in chronic hepatitis B,” World Journal of Hepatology, vol. 5, no. 8, pp. 439–445, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. N. Gara, X. Zhao, D. E. Kleiner, T. J. Liang, J. H. Hoofnagle, and M. G. Ghany, “Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C,” Clinical Gastroenterology and Hepatology, vol. 11, no. 3, pp. 303–308, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. R. A. Lesmana, S. Salim, I. Hasan et al., “Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting,” Journal of Clinical Pathology, vol. 64, no. 10, pp. 916–920, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. M. Lebensztejn, E. Skiba, M. Sobaniec-Lotowska, and M. Kaczmarski, “A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with chronic hepatitis B,” Hepatology, vol. 41, no. 6, pp. 1434–1435, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Güzelbulut, M. Sezıklı, Z. Akkan-Çetinkaya, B. Yaşar, S. Özkara, and A. O. Kurdaş-Övünç, “AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B,” The Turkish Journal of Gastroenterology, vol. 23, no. 4, pp. 353–358, 2012. View at Google Scholar · View at Scopus
  12. W. Jin, Z. Lin, Y. Xin, X. Jiang, Q. Dong, and S. Xuan, “Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis,” BMC Gastroenterology, vol. 12, article 14, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. G. K. Siberry, R. A. Cohen, D. R. Harris et al., “Prevalence and predictors of elevated aspartate aminotransferase-to-platelet ratio index in latin American perinatally HIV-infected children,” The Pediatric Infectious Disease Journal, vol. 33, no. 2, pp. 177–182, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. J. Díaz, K. M. Gura, J. Roda et al., “Aspartate aminotransferase to platelet ratio index correlates with hepatic cirrhosis but not with fibrosis in pediatric patients with intestinal failure,” Journal of Pediatric Gastroenterology and Nutrition, vol. 57, no. 3, pp. 367–371, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. H. R. Yang, H. R. Kim, M. J. Kim, J. S. Ko, and J. K. Seo, “Noninvasive Parameters and hepatic fibrosis scores in children with nonalcoholic fatty liver disease,” World Journal of Gastroenterology, vol. 18, no. 13, pp. 1525–1530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Y. Kim, J. Y. Seok, S. J. Han, and H. Koh, “Assessment of liver fibrosis and cirrhosis by aspartate aminotransferase-to-platelet ratio index in children with biliary atresia,” Journal of Pediatric Gastroenterology and Nutrition, vol. 51, no. 2, pp. 198–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. K. E. McGoogan, P. B. Smith, S. S. Choi, W. Berman, and R. Jhaveri, “Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis,” Journal of Pediatric Gastroenterology and Nutrition, vol. 50, no. 3, pp. 344–346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Kim, Y. Kang, S. Hahn, M. J. Lee, Y. N. Park, and H. Koh, “The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice,” Korean Journal of Pediatrics, vol. 56, no. 1, pp. 19–25, 2013. View at Publisher · View at Google Scholar · View at Scopus